A programmable DNA origami-based lateral flow assay (DO-LFA) that employs a triangular DNA origami nanostructure (TDON) as a tunable molecular scaffold offering a generalizable and scalable strategy for next-generation point-of-care diagnostics.
Abstract
Lateral flow assays (LFAs) are widely used in point-of-care diagnostics due to their rapid readout, low cost, and operational simplicity; however, their limited sensitivity hinders the detection of low-abundance biomarkers. Existing signal amplification strategies often fail to precisely modulate signal intensity while maintaining a simple and versatile platform. Here, we introduce a programmable DNA origami-based lateral flow assay (DO-LFA) that employs a triangular DNA origami nanostructure (TDON) as a tunable molecular scaffold. The TDON enables site-specific functionalization with diverse recognition elements (e.g., oligonucleotides, aptamers, and antigens) and reporter labels (Cy5 fluorophores), allowing independent control over the number of signal reporters per binding event. By systematically varying the Cy5 density (6, 12, or 30 labels per TDON), we achieve predictable signal amplification, with the 30-Cy5-TDON delivering a 3.25-fold higher signal than conventional DNA scaffolds. The platform is adapted to both sandwich and competitive LFA formats, demonstrating ultrasensitive detection of nucleic acids (limit of detection, LOD: 70 pM in serum), thrombin (LOD: 50 pM in saliva), and the small molecule digoxigenin (Dig) (LOD: 1.87 pM in saliva), with excellent specificity and performance in complex biological matrices. This work integrates the precision of DNA origami with the practical simplicity of LFAs, offering a generalizable and scalable strategy for next-generation point-of-care diagnostics.
The development of high-sensitivity biosensing architectures with integrated signal processing capabilities remains a cornerstone of molecular diagnostics. To address the requirements for ultralow-concentration detection, we developed a programmable and modular dual-amplification DNA fluorescent biosensor (DDFB). This...
Fang Wang, Ming Lei, Hong-Xin Lin et al.· IEEE Transactions on Nanobio...· 0 citations
Accessible molecular diagnostics is fundamental to effective healthcare. While most current point-of-care devices detect only the presence of a molecular biomarker(s), biomarker quantification can be equally important for decision-making on disease treatment and containment. Here, we present a diagnostic platform that...
A novel aptamer-based fluorescent sensor using Lettuce indicator, a light-up DNA aptamer that adopts a precise three-dimensional structure, which enables it to selectively bind and activate the otherwise non-fluorescent small-molecule fluorophore, generating a target-dependent fluorescent signal.
Xin Ji, Ran-Ran Hou, Hai Bao et al.· Analytical Chemistry· 0 citations
A semisynthetic affinity-activated protein switch strategy that enables Signal-ON detection of small molecules across diverse environments, including live cells, Drosophila brain, and lateral flow assays and establishes a generalizable framework for building programmable protein switches with tunable output modes and p...
Data-driven protein engineering has enabled biosensors that directly couple molecular recognition with measurable signal outputs, providing a powerful strategy for rapid protein analysis. However, their integration into automated and portable analytical systems remains limited. Here, we developed an integrated photoele...